National Health Investors (NYSE:NHI) - 주가, 뉴스 및 분석

NHI 주식 개요

1991년에 설립된 내셔널 헬스 인베스터스, Inc. 자세한 내용

NHI 기본 분석
눈송이 점수
가치 평가	4/6
미래 성장	2/6
과거 실적	3/6
재무 상태	3/6
배당금	5/6

보상

공정 가치 추정치보다 낮은 43.8% 에서 거래

수익은 매년 10.8% 증가할 것으로 예상됩니다.

위험 분석

부채는 영업현금흐름으로 충분히 감당되지 않습니다.

지난 1년 동안 주주가 희석되었습니다.

불안정한 배당 실적

National Health Investors, Inc. 경쟁사

Sabra Health Care REIT

NasdaqGS:SBRA

US$4.4b

CareTrust REIT

NYSE:CTRE

US$5.7b

LTC Properties

NYSE:LTC

US$1.8b

Sila Realty Trust

NYSE:SILA

US$1.4b

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 National Health Investors
과거 주가
현재 주가	US$77.71
52주 최고치	US$86.13
52주 최저치	US$51.59
베타	1.07
11개월 변경	3.38%
3개월 변경 사항	-2.14%
1년 변경 사항	43.11%
33년 변화	47.26%
5년 변화	-4.05%
IPO 이후 변화	281.40%

최근 뉴스 및 업데이트

National Health Investors: From Struggles To Strength

Sep 29

Recent updates

National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M

Feb 21

6%-Yielding National Health Investors: No Pain, No Gain

Feb 06

National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot

Sep 10

주주 수익률

	NHI	US Health Care REITs	US 마켓
7D	-0.04%	1.2%	2.2%
1Y	43.1%	34.8%	31.6%

수익률 대 산업: NHI 지난 1년 동안 34.8 %를 반환한 US Health Care REITs 산업을 초과했습니다.

수익률 대 시장: NHI 지난 1년 동안 31.6 %를 반환한 US 시장을 초과했습니다.

가격 변동성

Is NHI's price volatile compared to industry and market?
NHI volatility
NHI Average Weekly Movement	3.1%
Health Care REITs Industry Average Movement	3.1%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.7%
10% least volatile stocks in US Market	3.1%

안정적인 주가: NHI 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: NHI 의 주간 변동성( 3% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립	직원	CEO	웹사이트
1991	27	D. Mendelsohn	www.nhireit.com

1991년에 설립된 National Health Investors, Inc.(뉴욕증권거래소: NHI)는 판매, 리스백, 합작 투자, 노인 주택 운영 파트너십, 필요에 따른 재량적 노인 주택 및 의료 투자에 대한 모기지 및 메자닌 금융을 전문으로 하는 부동산 투자 신탁 회사입니다. NHI의 포트폴리오는 독립 생활, 원호 생활 및 메모리 케어 커뮤니티, 입장료가 있는 은퇴자 커뮤니티, 전문 간호 시설 및 전문 병원으로 구성되어 있습니다.

National Health Investors, Inc. 기본 사항 요약

National Health Investors 의 수익과 매출은 시가총액과 어떻게 비교하나요?
NHI 기본 통계
시가총액	US$3.53b
수익(TTM)	US$126.68m
수익(TTM)	US$329.85m

27.9x

P/E 비율

10.7x

P/S 비율

NHI 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
NHI 손익 계산서(TTM)
수익	US$329.85m
수익 비용	US$11.10m
총 이익	US$318.75m
기타 비용	US$192.07m
수익	US$126.68m

최근 보고된 수익

Sep 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)	2.79
총 마진	96.64%
순이익 마진	38.41%
부채/자본 비율	91.1%

NHI 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

배당금

4.6%

현재 배당 수익률

82%

지급 비율

NHI 신뢰할 수 있는 배당금을 지급하나요?

NHI 배당 내역 및 벤치마크 참조

예정된 배당금을 받으려면 언제까지 NHI 을 구매해야 하나요?
National Health Investors 배당 날짜
전 배당일	Dec 31 2024
배당금 지급일	Jan 29 2025
전 배당금까지의 일수	37 days
배당금 지급일까지의 일수	66 days

NHI 신뢰할 수 있는 배당금을 지급하나요?

NHI 배당 내역 및 벤치마크 참조

NHI 주식 개요

보상

위험 분석

National Health Investors, Inc. 경쟁사

NasdaqGS:SBRA

US$4.4b

NYSE:CTRE

US$5.7b

NYSE:LTC

US$1.8b

NYSE:SILA

US$1.4b

가격 내역 및 성능

최근 뉴스 및 업데이트

Third quarter dividend of US$0.90 announced

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

National Health Investors, Inc. Provides Earnings Guidance for the Full Year 2024

National Health Investors, Inc. to Report Q3, 2024 Results on Nov 05, 2024

National Health Investors: From Struggles To Strength

Senior VP & Chief Transaction Officer exercised options and sold US$752k worth of stock

Recent updates

Third quarter dividend of US$0.90 announced

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

National Health Investors, Inc. Provides Earnings Guidance for the Full Year 2024

National Health Investors, Inc. to Report Q3, 2024 Results on Nov 05, 2024

National Health Investors: From Struggles To Strength

Senior VP & Chief Transaction Officer exercised options and sold US$752k worth of stock

Upcoming dividend of US$0.90 per share

Executive VP of Finance exercised options and sold US$1.3m worth of stock

Executive VP & Chief Investment Officer exercised options and sold US$1.9m worth of stock

Price target increased by 12% to US$78.50

Independent Director exercised options to buy US$767k worth of stock.

New minor risk - Shareholder dilution

National Health Investors, Inc. has completed a Follow-on Equity Offering in the amount of $171 million.

National Health Investors, Inc. has filed a Follow-on Equity Offering.

Second quarter dividend of US$0.90 announced

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Provides Earnings Guidance for the Full Year 2024

Independent Director exercised options and sold US$656k worth of stock

National Health Investors, Inc. to Report Q2, 2024 Results on Aug 06, 2024

National Health Investors, Inc.(NYSE:NHI) dropped from Russell Small Cap Comp Growth Index

Land & Buildings Investment Management Comments on National Health Investors’ Supplemental Proxy Statement

First quarter dividend of US$0.90 announced

National Health Investors: The Lack Of Upside Seems Obvious To Me Here

National Health Investors, Inc. Announces Dividend for the Second Quarter of 2024, Payable on August 2, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting

National Health Investors, Inc. to Report Q1, 2024 Results on May 06, 2024

National Health Investors, Inc., Annual General Meeting, May 22, 2024

Upcoming dividend of US$0.90 per share

Price target increased by 7.2% to US$62.00

Insufficient new directors

Independent Director recently bought US$587k worth of stock

Price target increased by 7.5% to US$59.86

Fourth quarter dividend of US$0.90 announced

National Health: Lots To Love, But Valuation Still On The High Side

Full year 2023 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Provides Earnings Guidance for the Year 2024

National Health Investors, Inc. to Report Q4, 2023 Results on Feb 20, 2024

Upcoming dividend of US$0.90 per share at 6.3% yield

Catch The Senior Housing Rebound With National Health Investors

National Health Investors: 7% Yielding REIT Has Improved On Most Metrics

National Health Investors, Inc. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

National Health Investors, Inc. Announces Its Fourth Quarter Dividend, Payable on January 26, 2024

National Health Investors, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Upcoming dividend of US$0.90 per share at 7.1% yield

National Health Investors: Enjoy This Solid 7%+ Yield, For Now

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

National Health Investors, Inc. Announces Third Quarter 2023 Dividend, Payable on November 3, 2023

National Health Investors, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Upcoming dividend of US$0.90 per share at 6.8% yield

National Health: What We Got Wrong With This Healthcare REIT

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Announces Second Quarter 2023 Dividend, Payable on August 4, 2023

Full year 2022 earnings: EPS misses analyst expectations

National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M

6%-Yielding National Health Investors: No Pain, No Gain

National Health Investors, Inc. to Report Q4, 2022 Results on Feb 21, 2023